Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 603

1.

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC.

Neuroimage. 2005 Oct 1;27(4):934-46.

PMID:
15979341
2.

Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.

Chételat G, Fouquet M, Kalpouzos G, Denghien I, De la Sayette V, Viader F, Mézenge F, Landeau B, Baron JC, Eustache F, Desgranges B.

Neuropsychologia. 2008;46(6):1721-31. doi: 10.1016/j.neuropsychologia.2007.11.037. Epub 2008 Jan 16.

3.

The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.

Bozzali M, Filippi M, Magnani G, Cercignani M, Franceschi M, Schiatti E, Castiglioni S, Mossini R, Falautano M, Scotti G, Comi G, Falini A.

Neurology. 2006 Aug 8;67(3):453-60.

PMID:
16894107
4.

Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.

Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC.

Neuroreport. 2002 Oct 28;13(15):1939-43.

PMID:
12395096
5.

Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.

Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hänninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen R, Soininen H.

Neuroimage. 2007 Oct 1;37(4):1122-31. Epub 2007 Jun 29.

PMID:
17683950
6.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
7.

Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.

Chetelat G, Baron JC.

Neuroimage. 2003 Feb;18(2):525-41.

PMID:
12595205
8.

Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease--a VBM study.

Leube DT, Weis S, Freymann K, Erb M, Jessen F, Heun R, Grodd W, Kircher TT.

Int J Geriatr Psychiatry. 2008 Nov;23(11):1114-8. doi: 10.1002/gps.2036.

PMID:
18449954
9.

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P.

Neurobiol Aging. 2008 Jan;29(1):1-11. Epub 2006 Oct 19.

PMID:
17055615
10.

Cortical changes in incipient Alzheimer's disease.

Prestia A, Drago V, Rasser PE, Bonetti M, Thompson PM, Frisoni GB.

J Alzheimers Dis. 2010;22(4):1339-49. doi: 10.3233/JAD-2010-101191.

PMID:
20930288
11.

MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, Wuu J, Turner DA.

Neurobiol Aging. 2004 Oct;25(9):1197-203.

PMID:
15312965
12.

Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease.

Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M.

Neuroimage. 2006 Oct 15;33(1):17-26. Epub 2006 Aug 10.

PMID:
16904912
13.

VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.

Kinkingnéhun S, Sarazin M, Lehéricy S, Guichart-Gomez E, Hergueta T, Dubois B.

Neurology. 2008 Jun 3;70(23):2201-11. doi: 10.1212/01.wnl.0000303960.01039.43. Epub 2008 Apr 30.

PMID:
18448872
14.

Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment.

Grau-Olivares M, Bartrés-Faz D, Arboix A, Soliva JC, Rovira M, Targa C, Junqué C.

Cerebrovasc Dis. 2007;23(5-6):353-61. Epub 2007 Jan 30.

PMID:
17268166
15.

Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Göteborg MCI study.

Eckerström C, Olsson E, Borga M, Ekholm S, Ribbelin S, Rolstad S, Starck G, Edman A, Wallin A, Malmgren H.

J Neurol Sci. 2008 Sep 15;272(1-2):48-59. doi: 10.1016/j.jns.2008.04.024. Epub 2008 Jun 20.

PMID:
18571674
16.

Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.

Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.

Neuroimage. 2009 Mar 1;45(1):60-7. doi: 10.1016/j.neuroimage.2008.10.006. Epub 2008 Oct 25.

PMID:
19013533
17.

Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

Teipel SJ, Born C, Ewers M, Bokde AL, Reiser MF, Möller HJ, Hampel H.

Neuroimage. 2007 Oct 15;38(1):13-24. Epub 2007 Jul 18.

PMID:
17827035
18.

Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.

Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.

J Neurol Sci. 2009 Jul 15;282(1-2):55-60. doi: 10.1016/j.jns.2009.02.322. Epub 2009 Mar 16.

PMID:
19286193
19.

Increased fMRI responses during encoding in mild cognitive impairment.

Hämäläinen A, Pihlajamäki M, Tanila H, Hänninen T, Niskanen E, Tervo S, Karjalainen PA, Vanninen RL, Soininen H.

Neurobiol Aging. 2007 Dec;28(12):1889-903. Epub 2006 Sep 25.

PMID:
16997428
20.

Are the behavioral symptoms of Alzheimer's disease directly associated with neurodegeneration?

Serra L, Perri R, Cercignani M, Spanò B, Fadda L, Marra C, Carlesimo GA, Caltagirone C, Bozzali M.

J Alzheimers Dis. 2010;21(2):627-39. doi: 10.3233/JAD-2010-100048.

PMID:
20555138

Supplemental Content

Support Center